Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 18/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.53 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | ACACA | Q13085 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16637950 | 0.92 | ADORA2B (0.56) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL19611090 | 0.90 | ADORA2B (0.52) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL16637636 | 0.89 | ADORA2B (0.51) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL16637657 | 0.89 | ADORA2B (0.51) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL16637879 | 0.88 | ADORA2B (0.49) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL16637443 | 0.87 | ADORA2B (0.49) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL19611091 | 0.86 | ADORA2B (0.53) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL16637551 | 0.86 | ADORA2B (0.48) | ADORA2BADORA2AADORA1ADORA3ACACB | |
| SCHEMBL19611059 | 0.86 | ADORA2B (0.52) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL16637639 | 0.85 | ADORA2B (0.49) | ADORA2BADORA2AADORA1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3274352-B1 | HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR | Bayer Pharma AG (DE) | 2019-01-02 | — | — | EP | disclosed |
| EP-3274352-A1 | HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR | Bayer Pharma Aktiengesellschaft (DE) | 2018-01-31 | — | — | EP | disclosed |
| EP-3055313-B1 | CYCLIC THIENOURACIL CARBOXAMIDE AND ITS USE | Bayer Pharma AG (DE) | 2017-11-22 | — | — | EP | disclosed |
| WO-2016150901-A1 | HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-09-29 | — | — | WO | disclosed |